In addition to institutional restrictions on the use of funds, the CCIL and OSF seek to maximize the cancer impact of designated funds. Grant recipients will be responsible for ensuring that all expenditures directly relate to the proposed scope of work. If after review it is determined that certain expenditures made by a CCIL team member are not appropriate, the principal investigator’s (PI’s) unit will be responsible for bearing those costs. If after review it is determined that certain expenditures present on submitted invoices made by an OSF team member are not appropriate, OSF will be responsible for bearing those costs and will not be reimbursed.

Allowable costs include (but may not be limited to):

• Consumable supplies
• Contractual services
• Salaries for postdocs, graduate research assistants, student and academic hourly employees, clinical research nurses, clinical research coordinators, and ancillary staff
• Equipment
• Travel
• Non-employee travel
• Publication and/or printing costs
• Rental costs

Unallowable costs include (but may not be limited to):

• Alcohol
• Membership dues
• Subscriptions
• Principal investigator (tenure-track faculty) salaries
• Fringe benefits
• Tuition remission
• Service or maintenance contracts for equipment

Note: Please contact the BEAT Cancer Research Initiative Program Manager with further questions regarding allowable costs.

Yes, AP and/or CS staff can be paid from these grants as long as their efforts are directly related to the project.

Administrative support is not allowed, as it would be difficult to define effort solely on behalf of a project.

All expenditures must directly relate to your approved BEAT Cancer Research Initiative Grant project and any unspent funds will be pulled back to the CCIL.

Please contact the BEAT Cancer Research Initiative Program Manager to discuss the possibility of a no-cost extension.

Cost-sharing is not necessary and would not improve one’s funding chances.

Funds will be released when all required information is completely submitted (i.e., scope of work, unit business contact information, CFOP establishment, etc.) and assurance is made that the research is ready to be initiated.

Yes, persons doing cancer-related, cancer-focused, or cancer-relevant research are encouraged to join a team as a co-investigator (Co-I) to apply, but it is important to note that only CCIL members or OSF clinicians can serve as the principal investigator (Co-PI) on a team.

At least one of the team members must be a current CCIL member and one team member must be an OSF clinician. Each Co-PI is given the freedom to determine the project’s scientific and effort needs.

No – if a person is conducting cancer-relevant/focused research, they are eligible to participate on a team as a co-investigator (Co-I).

For any further inquiries, please email the BEAT Cancer Research Initiative Program Manager.